Moore Capital Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Moore Capital Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300,000	Closed	-$1.38M	–	887
2021 Q2	$1.38M	Hold	300,000	–	–	0.02%	503
2021 Q1	$1.52M	Sell	300,000 -33,333	-10%	-$185K	0.02%	483
2020 Q4	$910K	Buy	+333,333	New	+$838K	0.01%	418

Other funds holding WGSWW

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Moore Capital Management's WGSWW Position: Q3 2021 in Review

Moore Capital Management sold out of GeneDx Holdings Warrant (WGSWW) in Q3 2021, closing a stake of 300,000 shares — an estimated $1.38M sold.

Moore Capital Management first reported a position in WGSWW in Q4 2020 and held it in 3 quarters. The position peaked at $1.52M in Q1 2021. 35 funds tracked by Wall St. Rank hold WGSWW as of Q3 2021.

Moore Capital Management reported no remaining GeneDx Holdings Warrant position as of Q3 2021 after selling out during the quarter.
Moore Capital Management sold 300,000 GeneDx Holdings Warrant shares in Q3 2021, an estimated $1.38M.
Moore Capital Management first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 3 quarters.
Moore Capital Management's GeneDx Holdings Warrant position peaked at $1.52M in Q1 2021.
35 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q3 2021.

Based on Moore Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.